These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 15737190

  • 1. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL, Stern RS.
    J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
    [Abstract] [Full Text] [Related]

  • 2. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 3. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 4. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May 02; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 5. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr 02; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 6. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P.
    J Invest Dermatol; 2001 Aug 02; 117(2):365-70. PubMed ID: 11511317
    [Abstract] [Full Text] [Related]

  • 7. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul 02; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 8. Non-melanoma skin cancer, sun exposure and sun protection.
    Calzavara-Pinton P, Ortel B, Venturini M.
    G Ital Dermatol Venereol; 2015 Aug 02; 150(4):369-78. PubMed ID: 26186380
    [Abstract] [Full Text] [Related]

  • 9. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS.
    Br J Dermatol; 2008 Sep 02; 159(4):931-5. PubMed ID: 18834483
    [Abstract] [Full Text] [Related]

  • 10. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H.
    Dermatology; 1996 Sep 02; 193(3):185-91. PubMed ID: 8944338
    [Abstract] [Full Text] [Related]

  • 11. Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort.
    Bräuner EV, Loft S, Sørensen M, Jensen A, Andersen CE, Ulbak K, Hertel O, Pedersen C, Tjønneland A, Krüger Kjær S, Raaschou-Nielsen O.
    PLoS One; 2015 Sep 02; 10(8):e0135642. PubMed ID: 26274607
    [Abstract] [Full Text] [Related]

  • 12. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P.
    J Invest Dermatol; 2003 Apr 02; 120(4):676-82. PubMed ID: 12648234
    [Abstract] [Full Text] [Related]

  • 13. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS, Laird N.
    Cancer; 1994 Jun 01; 73(11):2759-64. PubMed ID: 8194017
    [Abstract] [Full Text] [Related]

  • 14. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED, Calva-Mercado JJ, Alberú-Gómez J, Vilatoba-Chapa M, Domínguez-Cherit J.
    Gac Med Mex; 2015 Jun 01; 151(1):20-6. PubMed ID: 25739480
    [Abstract] [Full Text] [Related]

  • 15. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.
    Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR.
    J Invest Dermatol; 2013 Aug 01; 133(8):1950-5. PubMed ID: 23344461
    [Abstract] [Full Text] [Related]

  • 16. UV dose determines key characteristics of nonmelanoma skin cancer.
    Ramos J, Villa J, Ruiz A, Armstrong R, Matta J.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 01; 13(12):2006-11. PubMed ID: 15598755
    [Abstract] [Full Text] [Related]

  • 17. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
    Wolf P, Kreimer-Erlacher H, Seidl H, Bäck B, Soyer HP, Kerl H.
    J Invest Dermatol; 2004 Jan 01; 122(1):190-200. PubMed ID: 14962108
    [Abstract] [Full Text] [Related]

  • 18. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE, Stern RS.
    J Invest Dermatol; 2003 Aug 01; 121(2):252-8. PubMed ID: 12880415
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB, Roenigk HH, Caro WA, Magid ML.
    Arch Dermatol; 1989 Apr 01; 125(4):515-9. PubMed ID: 2649011
    [Abstract] [Full Text] [Related]

  • 20. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study.
    Iannacone MR, Wang W, Stockwell HG, O'Rourke K, Giuliano AR, Sondak VK, Messina JL, Roetzheim RG, Cherpelis BS, Fenske NA, Rollison DE.
    BMC Cancer; 2012 Sep 20; 12():417. PubMed ID: 22994655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.